title: Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma.
authors.affiliation: Liver Transplantation Unit - Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: gfelga@einstein.br.
authors.forename: Guilherme
authors.initials: G
authors.lastname: Felga
authors.affiliation: Liver Transplantation Unit - Hospital Israelita Albert Einstein, São Paulo, Brazil.
authors.forename: Paolo Rogério
authors.initials: PR
authors.lastname: Salvalaggio
authors.affiliation: Liver Transplantation Unit - Hospital Israelita Albert Einstein, São Paulo, Brazil.
authors.forename: Marcelo Bruno
authors.initials: MB
authors.lastname: de Rezende
authors.affiliation: Liver Transplantation Unit - Hospital Israelita Albert Einstein, São Paulo, Brazil.
authors.forename: Marcio Dias
authors.initials: MD
authors.lastname: de Almeida
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D016031:Liver Transplantation; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000627:therapeutic use*
chemical_list: D010671:Phenylurea Compounds; D009536:Niacinamide